(Total Views: 465)
Posted On: 07/15/2025 10:11:34 PM
Post# of 155726

Well, at the very least we know that someone at Cytodyn is responding to the Patent Office:
Title: METHODS FOR TREATING OR PREVENTING CANCERS INVOLVING THE ADMINISTRATION OF ANTI-CCR5 RECEPTOR AGENTS
Application: 17631161
Docket: 230042.429USPC
New status: Response to Non-Final Office Action Entered and Forwarded to Examiner
Date of new status: 07/14/2025
Would this patent have any bearing on partnerships not being announced? No idea how or if it does. Steady as she goes...
Title: METHODS FOR TREATING OR PREVENTING CANCERS INVOLVING THE ADMINISTRATION OF ANTI-CCR5 RECEPTOR AGENTS
Application: 17631161
Docket: 230042.429USPC
New status: Response to Non-Final Office Action Entered and Forwarded to Examiner
Date of new status: 07/14/2025
Would this patent have any bearing on partnerships not being announced? No idea how or if it does. Steady as she goes...

